India’s new draft national policy for rare disease and the road to accessing gene therapies

By Ciaran Cassidy, Snr Analyst Email: ccassidy@partners4access.com With one of the fastest-growing economies and the second largest population in the world India is a market of increasing interest to the biopharmaceutical industry.1,2 However, the potential for access to innovative rare disease therapies, such as gene therapies, is not particularly well supported by the central government…

4 key trends changing the access landscape through to 2025

By Jens Leutloff, Senior Consultant Email: jleutloff@partners4access.com Partners4Access  asked payer experts from France, Germany, Italy, Spain, and the Nordics what the key trends are for market access by 2025. Besides the financial challenge posed by high-cost innovative therapies, they will also influence how other drugs will be looked at. An increasing number of innovative therapies…